Search Results

There are 78514 results for: content related to: Randomized, double-blind, placebo-controlled study of safety and efficacy of miltefosine in antihistamine-resistant chronic spontaneous urticaria

  1. You have free access to this content
    TLR9 and MyD88 are crucial for the maturation and activation of dendritic cells by paromomycin–miltefosine combination therapy in visceral leishmaniasis

    British Journal of Pharmacology

    Volume 171, Issue 5, March 2014, Pages: 1260–1274, Sushmita Das, Mukta Rani, Vidyanand Rabidas, Krishna Pandey, Ganesh Chandra Sahoo and Pradeep Das

    Version of Record online : 27 FEB 2014, DOI: 10.1111/bph.12530

  2. You have free access to this content
    Involvement of miltefosine-mediated ERK activation in glioma cell apoptosis through Fas regulation

    Journal of Neurochemistry

    Volume 107, Issue 3, November 2008, Pages: 616–627, Richa Tewari, Vivek Sharma, Nitin Koul and Ellora Sen

    Version of Record online : 14 AUG 2008, DOI: 10.1111/j.1471-4159.2008.05625.x

  3. Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double-blind, placebo-controlled trial

    British Journal of Dermatology

    Volume 162, Issue 1, January 2010, Pages: 185–190, K. Hartmann, F. Siebenhaar, B. Belloni, K. Brockow, R. Eben, B. Hartmann, F. Ruëff, N. Schoepke, P. Staubach, A. Weber and M. Maurer

    Version of Record online : 3 AUG 2009, DOI: 10.1111/j.1365-2133.2009.09434.x

  4. You have free access to this content
    Miltefosine-unresponsive Leishmania donovani has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species

    The FEBS Journal

    Volume 280, Issue 19, October 2013, Pages: 4807–4815, Mousumi Das, Prakash Saudagar, Shyam Sundar and Vikash K. Dubey

    Version of Record online : 23 AUG 2013, DOI: 10.1111/febs.12449

  5. Pharmacotherapy for Leishmaniasis in the United States: Focus on Miltefosine

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 35, Issue 5, May 2015, Pages: 536–545, Niyati H. Vakil, Noriko Fujinami and Punit J. Shah

    Version of Record online : 4 MAY 2015, DOI: 10.1002/phar.1585

  6. Topical formulations of miltefosine for cutaneous leishmaniasis in a BALB/c mouse model

    Journal of Pharmacy and Pharmacology

    Volume 68, Issue 7, July 2016, Pages: 862–872, Katrien Van Bocxlaer, Vanessa Yardley, Sudaxshina Murdan and Simon L. Croft

    Version of Record online : 27 MAY 2016, DOI: 10.1111/jphp.12548

  7. Immunoprotective effect of lentinan in combination with miltefosine on Leishmania-infected J-774A.1 macrophages

    Parasite Immunology

    Volume 38, Issue 10, October 2016, Pages: 618–627, R. Shivahare, W. Ali, U. S. Singh, S. M. Natu, S. Khattri, S. K. Puri and S. Gupta

    Version of Record online : 24 AUG 2016, DOI: 10.1111/pim.12346

  8. Can a simple outpatient-based treatment be used to treat cutaneous leishmaniasis in young children? A Critically Appraised Topic

    British Journal of Dermatology

    Volume 172, Issue 4, April 2015, Pages: 861–866, E. Burden-Teh, C.I. Wootton and H.C. Williams

    Version of Record online : 1 APR 2015, DOI: 10.1111/bjd.13496

  9. Experience with miltefosine for persistent or relapsing visceral leishmaniasis in solid organ transplant recipients: A case series from Spain

    Transplant Infectious Disease

    Volume 19, Issue 1, February 2017, Maria A. Pérez-Jacoiste Asín, Nerea Carrasco-Antón, Mario Fernández-Ruiz, Rafael San Juan, Rodrigo Alonso-Moralejo, Esther González, Amado Andrés, Francisco López-Medrano and Jose M. Aguado

    Version of Record online : 3 JAN 2017, DOI: 10.1111/tid.12623

  10. Oral miltefosine in post-kala-azar dermal leishmaniasis – experience in three cases

    International Journal of Dermatology

    Volume 49, Issue 5, May 2010, Pages: 565–569, Sujay Khandpur, Pankaj Chaturvedi, Uttam Kumar, Binod K. Khaitan, Jyotish C. Samantaray and Vinod K. Sharma

    Version of Record online : 26 APR 2010, DOI: 10.1111/j.1365-4632.2010.04326.x

  11. You have free access to this content
    LeishMan Recommendations for Treatment of Cutaneous and Mucosal Leishmaniasis in Travelers, 2014

    Journal of Travel Medicine

    Volume 21, Issue 2, March/April 2014, Pages: 116–129, Johannes Blum, Pierre Buffet, Leo Visser, Gundel Harms, Mark S. Bailey, Eric Caumes, Jan Clerinx, Pieter P.A.M. van Thiel, Gloria Morizot, Christoph Hatz, Thomas P.C. Dorlo and Diana N.J. Lockwood

    Version of Record online : 19 DEC 2013, DOI: 10.1111/jtm.12089

  12. Long-term reduction in local inflammation by a lipid raft molecule in atopic dermatitis

    Allergy

    Volume 65, Issue 9, September 2010, Pages: 1158–1165, S. Dölle, D. Hoser, C. Rasche, C. Loddenkemper, M. Maurer, T. Zuberbier and M. Worm

    Version of Record online : 10 MAR 2010, DOI: 10.1111/j.1398-9995.2010.02341.x

  13. In-Vitro Activity of Miltefosine and Voriconazole on Clinical Isolates of Free-Living Amebas: Balamuthia mandrillaris, Acanthamoeba spp., and Naegleria fowleri

    Journal of Eukaryotic Microbiology

    Volume 53, Issue 2, March 2006, Pages: 121–126, FREDERICK L. SCHUSTER, B. JOSEPH GUGLIELMO and GOVINDA S. VISVESVARA

    Version of Record online : 2 FEB 2006, DOI: 10.1111/j.1550-7408.2005.00082.x

  14. Interaction of miltefosine with the lipid and protein components of the erythrocyte membrane

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 5, May 2013, Pages: 1661–1669, Rodrigo Alves Moreira, Sebastião Antonio Mendanha, Daiane Hansen and Antonio Alonso

    Version of Record online : 1 MAR 2013, DOI: 10.1002/jps.23496

  15. You have free access to this content
    Treatment of Cutaneous Leishmaniasis in Travelers 2009

    Journal of Travel Medicine

    Volume 16, Issue 2, March/April 2009, Pages: 123–131, Johannes A. Blum and Christoph F. Hatz

    Version of Record online : 23 MAR 2009, DOI: 10.1111/j.1708-8305.2008.00286.x

  16. In vitro antifungal activity of miltefosine and levamisole: their impact on ergosterol biosynthesis and cell permeability of dimorphic fungi

    Journal of Applied Microbiology

    Volume 119, Issue 4, October 2015, Pages: 962–969, R.S.N. Brilhante, E.P. Caetano, R.A.C. Lima, D.S.C.M. Castelo Branco, R. Serpa, J.S. Oliveira, A.J. Monteiro, M.F.G. Rocha, R.A. Cordeiro and J.J.C. Sidrim

    Version of Record online : 14 AUG 2015, DOI: 10.1111/jam.12891

  17. Interventions for American cutaneous and mucocutaneous leishmaniasis

    Intervention Review

    The Cochrane Library

    Urbà González, Mariona Pinart, Mónica Rengifo-Pardo, Antonio Macaya, Jorge Alvar and John A Tweed

    Published Online : 15 APR 2009, DOI: 10.1002/14651858.CD004834.pub2

  18. You have free access to this content
    Effects of miltefosine on the proliferation, ultrastructure, and phospholipid composition of Angomonas deanei, a trypanosomatid protozoan that harbors a symbiotic bacterium

    FEMS Microbiology Letters

    Volume 333, Issue 2, August 2012, Pages: 129–137, Paulo R.G. de Freitas-Junior, Carolina M.C. Catta-Preta, Iamara da Silva Andrade, Danielle P. Cavalcanti, Wanderley de Souza, Marcelo Einicker-Lamas and Maria Cristina M. Motta

    Version of Record online : 18 JUN 2012, DOI: 10.1111/j.1574-6968.2012.02607.x

  19. You have free access to this content
    Multicentric, controlled clinical study to evaluate effectiveness and safety of miltefosine and allopurinol for canine leishmaniosis

    Veterinary Dermatology

    Volume 20, Issue 5-6, October/December 2009, Pages: 397–404, Guadalupe Miró, Gaetano Oliva, Israel Cruz, Carmen Cañavate, Michele Mortarino, Claudia Vischer and Paolo Bianciardi

    Version of Record online : 16 DEC 2009, DOI: 10.1111/j.1365-3164.2009.00824.x

  20. You have free access to this content
    Topical agents and dressings for fungating wounds

    Intervention Review

    The Cochrane Library

    Una J Adderley and Ian GS Holt

    Published Online : 15 MAY 2014, DOI: 10.1002/14651858.CD003948.pub3